CIK: 1612343 - Address: 21 Waterway Avenue Suite 225, The Woodlands, TX 77380
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
9/6/23 19:10
9/1/23
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumEw Healthcare Partners, L.P.TXTHSee footS.a-1989.900-20-13,491I
9/6/23 17:14
9/1/23
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumEw Healthcare Partners, L.P.TXTHSee footS-1989.900-20-13,491I
9/1/23 16:51
8/30/23
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumEw Healthcare Partners, L.P.TXTHSee footS.m-1,47010.540-139-43,511I
8/30/23 17:46
8/28/23
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumEw Healthcare Partners, L.P.TXTHSee footS.m-1,65711.140-149-43,650I
8/30/23 17:32
8/24/23
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumEw Healthcare Partners, L.P.TXTHSee footS.am-2,48711.110-224-63,799I
8/28/23 18:32
8/24/23
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumEw Healthcare Partners, L.P.TXTHSee footS.m-2,96813.250-224-63,799I
8/24/23 17:30
8/22/23
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumEw Healthcare Partners, L.P.TXTHSee footS.m-2,26513.490-168-44,023I
11/21/17 15:31
11/20/17
AXGNAxogen, Inc.MNHealthElcMdElectromedical & ElectrotheraEssex Woodlands Fund Ix, L.P.TXTS-22,70119.740-1,150-243,711D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact